Brief: Biogen Completes Acquisition Of Alcyone Therapeutics
Nov 14 (Reuters) - Biogen Inc BIIB.O: BIOGEN COMPLETES ACQUISITION OF ALCYONE THERAPEUTICS Source text: ID:nGNX1wQwh Further company coverage: BIIB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ionis Pharmaceuticals
See all newsUS FDA approves GSK's hepatitis B drug, offering patients chance to stop long-term treatment (updated)
US FDA approves GSK's hepatitis B drug, offering patients chance to stop long-term treatment
Focus: AI companies run virtual drug trials, aim to improve success of human studies
Brief: Ionis Pharmaceuticals Says Ulefnersen Demonstrates Favorable Safety And Tolerability Profile
Otsuka, Ionis' experimental ALS drug meets main goal in late-stage study